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Caveolin-3 is the major structural protein of caveolae in muscle. Mutations in the CAV3 gene
cause different types of myopathies with altered membrane integrity and repair, expression
of muscle proteins, and regulation of signaling pathways. We show here that myotubes from
patients bearing the CAV3 P28L and R26Q mutations present a dramatic decrease of
caveolae at the plasma membrane, resulting in abnormal response to mechanical stress.
Mutant myotubes are unable to buffer the increase in membrane tension induced by
mechanical stress. This results in impaired regulation of the IL6/STAT3 signaling pathway
leading to its constitutive hyperactivation and increased expression of muscle genes. These
defects are fully reversed by reassembling functional caveolae through expression of
caveolin-3. Our study reveals that under mechanical stress the regulation of mechan-
oprotection by caveolae is directly coupled with the regulation of IL6/STAT3 signaling in
muscle cells and that this regulation is absent in Cav3-associated dystrophic patients.
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Caveolae are cup-shaped plasma membrane invaginationsthat were ﬁrst observed in the 1950s by Palade and Yamadaon electron micrographs from vascular and gall bladder
tissues1,2. Caveolae present a speciﬁc protein signature involving
two main families of proteins, caveolins (caveolin-1, -2, and -3), and
cavins (cavin-1, -2, -3, and -4)3–9. Caveolins and cavins are
expressed in almost every cell type, except for caveolin-3 (Cav3) and
cavin-4, whose expression is restricted to smooth and striated
muscle cells9,10. Cav3, like Cav1 in non-muscle cells, is necessary for
the formation of caveolae at the plasma membrane of muscle cells11.
Caveolae have long been associated with several important
cellular functions including endocytosis, lipid metabolism, and
cell signaling, albeit with several persistent controversies12,13.
More recently, a new function of caveolae was established as
mechanosensors that play an essential role in cell mechan-
oprotection both in vitro and in vivo14–18. Mutations or abnor-
mal expression of caveolae components have been associated with
lipodystrophy, vascular dysfunction, cancer, and muscle
disorders13,19. The molecular mechanisms underlying caveolin-
associated diseases are still poorly understood.
In this study, we explored the mechanical role of caveolae in
human muscle cells and their possible deregulation in caveoli-
nopathies, a family of muscle genetic disorders involving muta-
tions in the CAV3 gene. These diseases affect both cardiac and
skeletal muscle tissues, and share common characteristics
including mild muscle weakness, high levels of serum creatine
kinase, variations in muscle ﬁber size, and an increased number
of central nuclei20–23. We focused our investigations on the
human CAV3 P28L mutation responsible for hyperCKemia24,
and CAV3 R26Q, which is responsible for ripple muscle disease,
hyperCKemia, and limb-girdle muscular dystrophy 1C25. Studies
with transgenic mice and zebraﬁsh or cells overexpressing the
Cav3 mutants have linked the P28L and R26Q CAV3 mutations
to deregulations in distinct signaling pathways22,25,26, defects in
membrane repair27,28, and mechanoprotection of the muscle
tissue16. Nevertheless, the role of the caveolae mechanoresponse
in human myotubes and its possible deregulation in dystrophy-
associated Cav3 mutations have not yet been addressed.
We show here that the Cav3 P28L and Cav3 R26Q myotubes
are unable to assemble sufﬁcient amounts of functional caveolae
at the plasma membrane, leading to a loss of membrane tension
buffering and membrane integrity under mechanical stress. The
absence of functional caveolae in mutant myotubes uncouples the
regulation of IL6/STAT3 signaling with mechanical stress, which
results in the constitutive hyperactivation of the IL6/
STAT3 signaling pathway and the upregulation of several muscle-
related genes. Finally, the expression of WT Cav3 in mutant
myotubes is sufﬁcient to restore a functional pool of caveolae and
to rescue the coupling of caveolae mechanosensing with IL6/
STAT3 signaling. These results establish caveolae as central
connecting devices that adapt intracellular signaling to mechan-
ical cues in muscle cells. The loss of this function in Cav3-
associated mutations may be responsible for some of the clinical
symptoms described in human dystrophic patients.
Results
Decrease of caveolae number in Cav3 mutant myotubes. To
address the impact of CAV3 mutations in human muscle dis-
orders, we analyzed wild type (WT), Cav3 P28L, and Cav3 R26Q
myotubes derived from immortalized myoblasts, which were
isolated from healthy or Cav3 mutant patients and differentiated
for 4 days. The state of myotube differentiation was validated by
the expression level of the differentiation marker MF20 (myosin
heavy chain) in all three cell lines (Supplementary Fig. 1a). We
ﬁrst analyzed the presence and the ultrastructure of caveolae at
the plasma membrane of myotubes by electron microscopy. In
WT myotubes, we observed numerous invaginated structures
corresponding to bona ﬁde caveolae i.e., characteristic 60–100 nm
cup-shaped invaginations that were connected to the plasma
membrane, or to larger vacuoles of variable size deeper inside the
cell known as rosettes, and that could still be connected to the
plasma membrane. In contrast, a lot less caveolae could be
detected at the plasma membrane of mutant myotubes and very
few, if any, large vacuolar structures were observed (Fig. 1a, b).
While we could still visualize a few caveolae in mutant myotubes,
they were often grouped in the same area and large areas of
plasma membrane were completely devoid of caveolae
(not shown). Interestingly, we could observe, mainly in mutant
myotubes, the presence of aberrant oversized caveolae (Fig. 1a).
This drastic decrease in caveolae number led us to investigate
the localization of Cav3, which is required for caveolae assembly
at the plasma membrane11. Immunoblot analysis showed a
reduced expression of mutant Cav3 (P28L: −50%; R26Q: −51%)
as compared to WT (Fig. 1c), with a shifted band for the R26Q
mutant corresponding to the Cav3 mutant form, as reported
previously25. Cav3 immunostaining revealed that WT Cav3 was
mainly associated with the plasma membrane of myotubes and
partially localized in the Golgi complex, deﬁned by
GM130 staining (Fig. 1d). In contrast, Cav3 strongly accumulated
in the Golgi complex as shown by the colocalization with GM130
in the Cav3 P28L and R26Q myotubes, in agreement with earlier
studies25,26. This indicates that the strong reduction in the
number of caveolae present at the plasma membrane of the Cav3
mutant myotubes is a consequence of the abnormal retention of
mutant Cav3 in the Golgi complex.
Since myoblasts express Cav1 but not Cav3, differentiated
myotubes might still express Cav1, which could potentially
participate in the formation of caveolae independently from Cav3.
We therefore analyzed Cav1 expression in myotubes after 4 days
of differentiation and found that Cav1 was indeed expressed to
the same level in all three cell lines (Supplementary Fig. 1b). Cav1
colocalized perfectly with Cav3 at the plasma membrane and to a
lesser extent at the Golgi complex in WT myotubes, whereas it
was mainly present in the Golgi complex in Cav3 P28L and R26Q
myotubes (Supplementary Fig. 1c, d). Finally, we used giant
plasma membrane vesicles (GPMVs) isolated from myotubes to
unambiguously determine the localization of Cav1 and
Cav3 since GPMVs are composed of plasma membrane and
cytosol while excluding other subcellular compartments29 (see
Supplementary Methods). GPMVs biochemical analysis con-
ﬁrmed that Cav3 was not present at the plasma membrane of
Cav3 P28L and R26Q myotubes. While Cav1 was also present at
the plasma membrane of WT myotubes, it was much less
abundant in mutant myotubes (Supplementary Fig. 1e). Alto-
gether, these data indicate that Cav1 is likely to form hetero-
oligomers with Cav3, and that the Cav3 P28L and R26Q mutants
have a dominant effect on Cav1 localization.
Tension buffering and mechanoprotection defects in Cav3
mutants. To know whether the almost total absence of caveolae
at the plasma membrane of mutant myotubes could induce
defects in cell mechanoprotection, we ﬁrst determined if the Cav3
P28L and R26Q myotubes could buffer the increase of membrane
tension induced by mechanical stress. We thus applied a 45
mOsm hypo-osmotic shock to myotubes aligned by micro-
patterning and we measured the apparent membrane tension
before and after 5 min of hypo-osmotic shock using membrane
nanotube pulling with optical tweezers as described14. As
expected, hypo-osmotic shock led to myotube swelling in WT
and Cav3 mutant cells (Fig. 2b). While mutant myotubes showed
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Fig. 1 Characterization of caveolae and Cav3 expression in WT, Cav3 P28L, and Cav3 R26Q myotubes. a Electron micrographs of WT, Cav3 P28L, and Cav3
R26Q myotubes. Caveolae, interconnected caveolae, and aberrant sized caveolae are indicated with black arrowheads, asterisks, and white arrowheads,
respectively. b Quantiﬁcation of the number of caveolae/µm2 in a. c Immunoblot analysis (lower panel) and quantiﬁcation (upper panel) of total levels of
Cav3 in WT, Cav3 P28L, and Cav3 R26Q differentiated myotubes. Tubulin serves as a loading control. Quantiﬁcation of the expression of Cav3 by calculating
the ratio between Cav3 and tubulin expression. d Immunoﬂuorescent labeling of Cav3 and GM130 in WT, Cav3 P28L, or Cav3 R26Q myotubes analyzed by
confocal microscopy. Arrows in inset indicate the plasma membrane and arrowheads indicate the Golgi complex. Cav1 staining is shown in Supplementary
Fig. 1c. a Scale bar= 200 nm. Representative cells quantiﬁed in b (number of regions analyzed: WT= 115, P28L= 154, R26Q= 146; total area screened: WT
= 1140 µm2, P28L= 1187 µm2, R26Q= 1216 µm2). Reproducibility of experiments: a Representative cells. a, c, d Representative data. b, c Quantiﬁcation was
done on 3 independent experiments. d Quantiﬁcation was done on 3 independent experiments (WT n= 24 cells, P28L n= 27 cells, R26Q n= 17 cells). Mean
value ± SEM. b, c Statistical analysis with a two-tailed unpaired t test. d Statistical analysis with a one-way ANOVA *P < 0.05; ***P < 0.001; ****P < 0.0001
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no signiﬁcant changes in membrane tension in resting condition
(Fig. 2a), they showed a signiﬁcant increase of membrane tension
(P28L: 63 ± 7%; R26Q: 94 ± 11%) under 45 mOsm hypo-osmotic
shock compared to WT myotubes (38 ± 9%) (Fig. 2b). These
results clearly show that the Cav3 P28L and R26Q mutant
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Fig. 2 Cav3 mutant myotubes present major defects in membrane tension buffering and integrity. a, b Membrane tension measurement analysis using
optical tweezers and nanotube pulling on micropatterned WT, Cav3 P28L, or Cav3 R26Q myotubes. Membrane tethers were pulled in the perpendicular
axis of aligned myotubes after micropatterning in resting conditions and 5min after a 45mOsm hypo-osmotic shock (a, b, left panels). Membrane tension
was analyzed in resting condition (a, right panel) and the difference of membrane tension before and after hypo-osmotic shock was calculated, reﬂecting
the percentage of increase of membrane tension upon mechanical stress (b, right panel). c, e Micropatterned WT, Cav3 P28L, or Cav3 R26Q myotubes
(c) or WT ctl (siCtl) and Cav3-depleted (siCav3) myotubes (e) were loaded with calcein-AM (green). The medium was switched with a 30mOsm medium
supplemented with propidium iodide (PI, red). Representative pictures were taken at the indicated times during hypo-osmotic shock. Arrows correspond to
myotubes and asterisks correspond to burst myotubes. d, f Quantiﬁcation of the percentage of burst myotubes (upper panel) and mean time of bursting in
minutes (lower panel) in c and e, respectively. a, b Scale bar= 5 µm. c, e Scale bar= 120 µm. Reproducibility of experiments: a Representative pictures and
quantiﬁcations from 7 independent experiments (WT n= 20 cells, P28L n= 23 cells, and R26Q n= 22 cells). b Representative pictures and quantiﬁcations
from 7 independent experiments (WT n= 20 cells, P28L n= 27 cells, and R26Q n= 18 cells). c Representative data of 3 independent experiments
quantiﬁed in d (% burst cells: WT n= 310 cells, P28L n= 299 cells, and R26Q n= 271 cells; mean time of bursting: WT n= 165 cells, P28L n= 233 cells,
and R26Q cells n= 240 cells). e Representative data of 3 independent experiments quantiﬁed in f (% burst cells: siCtl n= 749 cells and siCav3 n= 569
cells; mean time of bursting: siCtl n= 171 cells and siCav3 n= 506 cells). a, d, f Mean value ± SD. b Mean value ± SEM. a, b Statistical analyses were done
using Kruskal–Wallis test. d, f Statistical analysis with two-tailed unpaired t test; *P < 0.05; ***P < 0.001
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myotubes have lost the ability to buffer membrane tension var-
iations induced by mechanical stress.
We next tested whether the lack of membrane tension
buffering could result in insufﬁcient mechanoprotection and
increased membrane fragility in mechanically challenged mutant
myotubes. We designed an assay to quantify the percentage of
cells that rupture their membrane under mechanical stress. To
monitor membrane bursting, micropatterned myotubes were
incubated with calcein-AM, a permeant green ﬂuorescent dye
that only becomes ﬂuorescent inside the cell, and with the
nucleus-speciﬁc blue dye DAPI to speciﬁcally visualize differ-
entiated myotubes by nucleus staining (Supplementary Fig. 2a).
Live imaging was performed on myotubes subjected to a 30
mOsm hypo-osmotic shock for 10 min in the presence of
propidium iodide (PI), a non-permeant red ﬂuorescent dye that
cannot enter cells with intact plasma membrane. The concomi-
tant decrease of calcein-AM ﬂuorescence and the appearance of
PI ﬂuorescence in the nucleus indicate a loss of membrane
integrity (Fig. 2c). In comparison to WT myotubes, Cav3 mutant
myotubes not only showed a higher percentage of burst cells after
a 10 min hypo-osmotic shock (WT: 53 ± 3%; P28L: 78 ± 2%;
R26Q: 89 ± 2%) but also a shorter time of resistance to membrane
bursting (WT: 4.5 ± 0.2 min, P28L: 2.1 ± 0.1 min, R26Q: 2.7 ± 0.2
min) (Fig. 2d). When we apply a milder hypo-osmotic shock
(150 mOsm), for which no increase in membrane tension could
be measured, the plasma membrane of all three cell lines
remained intact after 10 min of shock (Supplementary Fig. 2b, c).
We repeated these experiments in WT myotubes depleted for
Cav3 and measured a percentage of burst cells that was similar to
mutant myotubes (siCtl: 23 ± 1%, siCav3: 89 ± 1%) (Fig. 2e, f;
Supplementary Fig. 2d). Likewise, Cav3-depleted myotubes
showed a signiﬁcantly faster time of bursting as compared to
control myotubes (siCtl: 3.1 ± 0.2 min, siCav3: 2.4 ± 0.1 min)
(Fig. 2e, f). Together, our results demonstrate that the Cav3
P28L and R26Q mutant myotubes are unable to provide the
mechanoprotection that is required to maintain the integrity of
the myotube plasma membrane under mechanical stress and
behave similarly to myotubes depleted for Cav3.
Hyperactivation of IL6/STAT3 signaling in Cav3 mutant
myotubes. Considering the key role of caveolae and caveolin in
intracellular signaling12,13, we next investigated whether the loss
of functional caveolae could impact some of the key signaling
pathways in the muscle. We focused our analysis on the IL6/
STAT3 signaling pathway that has been associated with satellite
cell exhaustion and muscle wasting30–32. Furthermore, the
IL6 signal transducer glycoprotein gp130, which, together with
the IL6 receptor subunit, assemble the IL6 receptor, has been
localized in caveolae in a myeloma cell line33, suggesting a
potential regulation of the IL6 signaling pathway by caveolae. IL6
binding to the IL6 receptor is classically followed by the activation
of receptor-bound JAK1 and JAK2 kinases, which in turn phos-
phorylate the signal transducer and activator of transcription 3
(STAT3) that is then translocated as a dimer to the nucleus where
it activates the transcription of IL6 sensitive genes34.
We therefore monitored the level of STAT3 activation, i.e.,
tyrosine (Tyr705) phosphorylation (pSTAT3) in myotubes
stimulated for 5 and 15 min with physiological concentrations
of IL6 (Fig. 3). At steady state, in the absence of IL6 stimulation,
little tyrosine phosphorylation of STAT3, if any, could be detected
in WT myotubes. In contrast, we found a substantially higher
level of pSTAT3 in Cav3 P28L and R26Q mutant myotubes, even
in the absence of IL6 stimulation. While IL6 stimulation led to
increased levels of pSTAT3 in WT myotubes, we still observed
higher levels of pSTAT3 in Cav3 P28L and R26Q mutant
myotubes for similar times of IL6 stimulation (Fig. 3a, b). We
could rule out the higher expression of STAT3 in Cav3 P28L
mutant myotubes as responsible for STAT3 hyperactivation since
Cav3 R26Q mutant myotubes, which express STAT3 at levels
identical to WT myotubes, showed the same hyperactivation of
STAT3. To eliminate the possible contribution of undifferentiated
myotubes in IL6 signaling, we investigated the nuclear transloca-
tion of pSTAT3 by immunoﬂuorescence since differentiated
myotubes are characterized by the presence of multiple nuclei
(Fig. 3c, d). Again, we detected a signiﬁcantly higher level of
pSTAT3 in the nuclei of mutant myotubes as compared to WT at
steady state. After 15 min of IL6 stimulation, mutant myotubes
exhibited higher pSTAT3 nuclear translocation, although it was
less pronounced in P28L mutants. Altogether, these data reveal
that the IL6/STAT3 signaling pathway is constitutively hyper-
activated in the Cav3 P28L and R26Q mutant myotubes.
We next investigated whether the regulation of IL6/
STAT3 signaling would require the presence of functional
caveolae at the plasma membrane and thus the expression of
Cav3. We therefore monitored the kinetics of STAT3 activation by
IL6 in WT myotubes depleted for Cav3. Immunoblot analysis
showed a hyperactivation of the IL6 pathway in Cav3-depleted
myotubes with an overall activation of STAT3 (Fig. 3e, f). In
contrast to Cav3 P28L and R26Q myotubes, STAT3 was not
activated in the absence of IL6 stimulation. This could be due to
the compensation of the loss of Cav3 by Cav1 at the plasma
membrane since it is unlikely that Cav1 will be retained in the
Golgi apparatus in siCav3 WT myotubes. These results indicate
that Cav3 is a negative regulator of the IL6/STAT3 pathway in
healthy myotubes and that the depletion of Cav3 in WT myotubes
reproduces to some extent the phenotype observed in the Cav3
mutants. It suggests that the absence of Cav3 and/or caveolae at
the plasma membrane of mutant myotubes is responsible for the
constitutive hyperactivation of the IL6/STAT3 signaling pathway.
STAT3 is a key transcription factor controlling the transcrip-
tion of many downstream genes whose products mediate the
pleiotropic effects of STAT3 in physiological and pathological
contexts35. We therefore examined the consequences of the
constitutive hyperactivation of the IL6/STAT3 pathway on gene
expression. In the context of muscle disease, we investigated the
transcription of muscle-related genes since STAT3 has been
suggested to be involved in their regulation. We focused our
analysis on the SOCS3, MYH8, ACTC1, and ACTN2 genes that
are associated with muscle development and regeneration32.
SOCS3 serves also as a positive control, as it is transcribed upon
STAT3 activation and its gene product SOCS3 is a major actor in
the negative regulation of this pathway34. Using quantitative PCR,
we found an increased transcription of SOCS3, MYH8, ACTC1,
and ACTN2 genes (Fig. 3g). These data strongly suggest that the
constitutive hyperactivation of STAT3 found in the Cav3 P28L
and R26Q mutant myotubes is responsible for the deregulation of
several genes involved in muscle pathophysiology.
IL6/STAT3 mechanosignaling is impaired in Cav3 mutant
myotubes. Although caveolae and caveolins have long been asso-
ciated with signaling12,13, the integration of this function with their
role in mechanosensing has not yet been reported. We have pro-
posed the hypothesis that the mechano-dependent cycle of caveolae
disassembly and reassembly could impact some of the caveolae-
dependent signaling pathways13,36. We thus analyzed whether the
regulation of the IL6/STAT3 pathway by caveolae could depend on
mechanical stress. When myotubes were subjected to hypo-osmotic
shock prior to IL6 stimulation, we observed a dramatic decrease of
STAT3 activation (approx. 80%) in WT myotubes whereas no
signiﬁcant change was observed in Cav3 P28L and R26Q mutant
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09405-5 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:1974 | https://doi.org/10.1038/s41467-019-09405-5 | www.nature.com/naturecommunications 5
a0 5 15 0 5 15 0 5 15
WT P28L R26Q
Tubulin
STAT3
pSTAT3 79 kDa
55 kDa
79 kDa
IL6 (min)
Tubulin 55 kDa
b
0.0
0.5
1.0
1.5
2.0
2.5
(p
S
T
A
T
3/
tu
b)
/
(S
T
A
T
3/
tu
b)
0 5 15 0 5 15 0 5 15
WT P28L R26Q
IL6 (min)
ns
ns
ns
ns ns ns
c
pS
T
A
T
3
pS
T
A
T
3
C
on
tr
ol
WT P28L R26Q
IL
6 
(1
5 
m
in
)
pS
T
A
T
3 
+
 D
A
P
I
pS
T
A
T
3 
+
 D
A
P
I
d
0
1
2
3
4
0
5
10
15
pS
T
A
T
3
nu
cl
eu
s/
cy
to
pl
as
m
WT P28L R26Q WT P28L R26Q
Control IL6 (15 min)
*
*
ns
**
0
1
2
3
4
5
0
5
10
15
20
25
0
10
20
30
40
0
2
4
6
8
ACTN2
WT P28L R26QWT P28L R26Q
SOCS3
F
ol
d 
ch
an
ge
(2
-Δ
ΔC
t  v
al
ue
s)
WT P28L R26Q WT P28L R26Q
MYH8 ACTC1
*
*
*
* **
**
**
g
e
pSTAT3
STAT3
Tubulin
Cav3
0 5 15 0 155
siCtl siCav3
IL6 (min)
79 kDa
79 kDa
55 kDa
21 kDa
Tubulin 55 kDa
f
0.0
0.5
1.0
1.5
2.0
2.5
0 5 15 0 5 15
siCtl siCav3
IL6 (min)
(p
S
T
A
T
3/
tu
b)
/
(S
T
A
T
3/
tu
b)
***
ns
ns
Fig. 3 Constitutive hyperactivation of IL6/STAT3 signaling in Cav3 mutant myotubes. a Immunoblot analysis of pSTAT3 and STAT3 levels in WT, Cav3
P28L, and Cav3 R26Q myotubes stimulated for the indicated times with 10 ng mL−1 IL6. Tubulin serves as a loading control. b Quantiﬁcation of STAT3
activation of a, corresponding to the ratio pSTAT3 on STAT3 total levels after normalization to tubulin levels. c Confocal microscopy of immunoﬂuorescent
pSTAT3 in WT, Cav3 P28L, and Cav3 R26Q myotubes stimulated or not for 15 min with 10 ngmL−1 IL6. White dashed lines outline nucleus boundaries.
d Quantiﬁcation of pSTAT3 nuclear translocation in c corresponding to nuclei/cytoplasm mean intensity ratio of pSTAT3. e Immunoblot analysis of
pSTAT3 levels in WT ctl (siCtl) and Cav3-depleted (siCav3) myotubes stimulated for the indicated times with 10 ngmL−1 IL6. f Quantiﬁcation of STAT3
activation in e, corresponding to the ratio pSTAT3 on STAT3 total level after normalization with tubulin level. g Expression of STAT3 related genes: from
left to right SOCS3, MYH8, ACTC1, and ACTN2 in WT, Cav3 P28L, or Cav3 R26Q myotubes. c Scale bar= 10 µm. Reproducibility of experiments: a, c, e
Representative data. b Quantiﬁcation was done on 4 independent experiments. d Quantiﬁcation was done on 3 independent experiments (0 min: WT n=
41 cells, P28L n= 25 cells, R26Q n= 21 cells; 15 min: WT n= 22 cells, P28L n= 30 cells, R26Q n= 30 cells). f Quantiﬁcation was done on 4 experiments.
g Quantiﬁcation was done on 5 (SOCS3), 8 (MYH8), 3 (ACTC1), and 7 (ACTN2) independent experiments. Mean value ± SEM. b, f Statistical analysis with
two-tailed paired t test. d, g Statistical analysis with two-tailed unpaired t test *P < 0.05; **P < 0.01; ***P < 0.001; ns non-signiﬁcant
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myotubes (Fig. 4a, b). We also tested the effect of mechanical
stretching on IL6/STAT3 signaling as this is more relevant to the
nature of mechanical stress experienced by skeletal muscles during
exercise. When we applied a 10% cyclic stretch at 0.5 Hz for 30min
to WT myotubes followed by IL6 stimulation, we also observed a
drastic reduction of STAT3 activation, conﬁrming that the IL6/
STAT3 pathway is tightly regulated by mechanical stress in muscle
cells (Supplementary Fig. 3).
We next determined whether the mechanical regulation of
IL6 signaling required the presence of functional caveolae. We
applied a hypo-osmotic shock to WT myotubes depleted of Cav3
and whereas no effect was observed at steady state, we found that
STAT3 activation by IL6 was slightly decreased by mechanical
stress (approx. 20%) in WT myotubes. The decrease of STAT3
activation was more pronounced when the analysis was restricted
to the translocation of STAT3 in the nuclei of fully differentiated
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Fig. 4 IL6/STAT3 mechanosignaling is impaired in Cav3 P28L and R26Q myotubes. a, c Immunoblot analysis of pSTAT3 and STAT3 levels in WT, Cav3
P28L, and Cav3 R26Q myotubes (a), and WT ctl (siCtl) or Cav3-depleted (siCav3) myotubes (c) subjected or not to a 75mOsm hypo-osmotic shock
(Hypo-Osm) for 10 min, followed by stimulation or not with 10 ngmL−1 IL6 for 5 min. Tubulin serves as loading control. b, d Quantiﬁcation of STAT3
activation in a and c respectively, corresponding to the ratio pSTAT3 on STAT3 total level after normalization to tubulin level. e Confocal microscopy of
immunoﬂuorescent pSTAT3 in WT (siCtl) and Cav3-depleted (siCav3) myotubes subjected or not to a 75mOsm hypo-osmotic shock (Hypo-Osm) for 5
min, followed by stimulation or not with 10 ng mL−1 IL6 for 15 min. White dashed lines outline nucleus boundaries. f Quantiﬁcation of pSTAT3 nuclear
translocation in e corresponding to the mean intensity of the nuclei/cytoplasm pSTAT3 ratio. e Scale bar= 10 µm. Reproducibility of experiments: a, c, e
Representative data. b Quantiﬁcation was done on 5 and 3 independent experiments for WT and mutants, respectively. d Quantiﬁcation was done on 4
independent experiments. f Quantiﬁcation was done on 3 independent experiments (Iso-Osm: siCtl n= 49 cells, siCav3 n= 50 cells; Hypo-Osm: siCtl n=
58 cells, siCav3 n= 57 cells). Mean value ± SEM. b, d Statistical analysis with two-tailed paired t test. d Statistical analysis with a one-way ANOVA *P <
0.05; **P < 0.01; ns non-signiﬁcant
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myotubes so as to rule out a possible contamination by myoblasts
(Fig. 4e, f). More importantly, no changes were observed in Cav3-
depleted myotubes (Fig. 4c–f). The poor adhesion of Cav3 P28L
and R26Q mutant myotubes on the stretching membrane did not
allow us to conﬁrm these data under cyclic stretching. Never-
theless, these results conﬁrm that the IL6/STAT3 signaling
pathway is negatively regulated by mechanical stress in myotubes
and that this regulation is lost in the absence of functional
caveolae as shown in Cav3 P28L and R26Q mutant myotubes and
in WT myotubes depleted for Cav3.
WT Cav3 expression rescue a normal phenotype in Cav3 P28L
myotubes. Our experiments showing that the depletion of Cav3 in
WT myotubes faithfully reproduces the mechanoprotection and
signaling defects observed in P28L and R26Q myotubes, implies
that the absence of Cav3 at the plasma membrane, as a result of its
abnormal retention in the Golgi complex, is responsible for the
observed phenotype. To validate this hypothesis, we generated
stable WT and P28L myoblasts transduced either by GFP alone or
by WT Cav3 tagged with GFP (Cav3-GFP). Immunoﬂuorescent
microscopy conﬁrmed that expressed Cav3-GFP was mainly loca-
lized at the plasma membrane and not retained at the Golgi com-
plex in Cav3-GFP P28L myotubes (Fig. 5a and Supplementary
Fig. 4a). We performed electron microscopy to see whether Cav3
WT expression would allow us to reconstitute a pool of structurally
deﬁned caveolae at the plasma membrane of Cav3 P28L myotubes
expressing GFP or Cav3-GFP. While the plasma membrane of
control GFP myotubes presented few, often isolated, caveolae
structures, Cav3-GFP rescued myotubes presented a signiﬁcantly
higher number of bona ﬁde caveolae, including larger vacuolar
structures with connected caveolae, i.e., rosettes (Fig. 5b, c), as
classically observed in WT myotubes (Fig. 1a). These observations
conﬁrm that the decrease in the number of caveolae in Cav3 P28L
myotubes is a direct consequence of the retention of Cav3 P28L in
the Golgi complex.
Next, we examined whether the reconstitution of the caveolae
reservoir at the plasma membrane of Cav3 P28L myotubes was
sufﬁcient to rescue the regulatory role of caveolae in mechan-
oprotection and IL6/STAT3 signaling. We therefore monitored
the resistance to membrane bursting of GFP- and WT Cav3-GFP
expressing P28L myotubes as described above. Notably, Cav3-
GFP P28L myotubes showed a strong increase in the resistance to
membrane bursting under hypo-osmotic shock as compared to
GFP P28L myotubes (GFP: 49 ± 3%; Cav3-GFP: 18 ± 2%). It also
took a signiﬁcantly longer time for Cav3-GFP P28L myotubes to
burst as compared to GFP P28L myotubes (GFP: 1.6 ± 0.1 min;
Cav3-GFP: 2.3 ± 0.2 min) (Fig. 6a, b). WT myotubes expressing
Cav3-GFP presented a bursting fraction (27 ± 2%) identical to
others control cells such as WT myotubes transfected with siCtrl
(Fig. 2f and Supplementary Fig. 4b). Consistently, the bursting
times of WT myotubes+GFP and WT+Cav3-GFP myotubes
were similar (GFP: 3.4 ± 0.3 min; Cav3-GFP: 3.9 ± 0.2 min). The
slightly higher resistance to bursting observed in WT myotubes
expressing GFP only may be due to the higher level of cell
differentiation that we observed in these cells (mean number of
nuclei/cell: GFP= 6.45 ± 0.25; Cav3-GFP= 4.1 ± 0.12).
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Finally, we analyzed the regulation of the IL6/STAT3 pathway
by monitoring STAT3 phosphorylation and nuclear translocation
in GFP and Cav3-GFP expressing P28L myotubes. At steady
state, we observed a signiﬁcant decrease of pSTAT3 activation
and nuclear translocation in Cav3-GFP P28L myotubes as
compared to GFP P28L myotubes, indicating that the expression
of Cav3 was sufﬁcient to reduce the hyperactivation of STAT3
observed at steady state in Cav3 P28L myotubes (Fig. 6c, d). Upon
IL6 stimulation, we measured a slightly decreased but not
signiﬁcant pSTAT3 nuclear translocation in Cav3-GFP P28L
myotubes, similarly to what we observed when comparing WT to
non-transduced Cav3 P28L myotubes (Figs. 3d and 6d). We also
found that the expression of Cav3-GFP in WT myotubes led to a
decrease of pSTAT3 activation and nuclear translocation at steady
state as compared to non-transduced WT myotubes (Supple-
mentary Fig. 4c). Importantly, the expression of Cav3-GFP in
Cav3-P28L mutant myotubes led to a signiﬁcant decrease of IL6-
induced pSTAT3 nuclear translocation under hypo-osmotic
conditions in contrast to Cav3-P28L myotubes expressing GFP
only (Fig. 6e, f). Altogether, these results show that Cav3
expression allows its localization at the plasma membrane of
P28L myotubes, which is sufﬁcient to restore membrane
mechanoprotection and the regulation of IL6/STAT3 signaling
by caveolae mechanics.
Discussion
In the present work, we investigated two aspects of caveolae that
have been so far poorly characterized in human muscle cells. We
ﬁrst addressed the role of caveolae in mechanosensing and
mechanoprotection, a new function of caveolae that has been
recently established by several investigators in various cell types.
When cells experience acute mechanical stress such as cell swel-
ling or cell stretching, caveolae ﬂatten out into the plasma
membrane to provide extra membrane area and prevents mem-
brane tension increase and membrane rupture14–18. In agreement
with these studies, we found that the presence of functional
caveolae was absolutely required to protect human myotubes
against severe mechanical stress. Thus, the Cav3 P28L and R26Q
mutant myotubes presented a major defect in mechanoprotection
with a lack of membrane tension buffering and increased sensi-
tivity to membrane rupture. Whereas the mutant myotubes
showed a dramatic decrease in the number of caveolae present at
the plasma membrane, the expression of wild type Cav3 allowed
to restore a number of caveolae sufﬁcient to restore mechan-
oprotection. The depletion of Cav3 in healthy myotubes repro-
duced the phenotypes observed in Cav3 P28L and R26Q
myotubes indicating that the retention of Cav3 in the Golgi
complex is responsible for the absence of a functional reservoir of
caveolae at the plasma membrane and thereby the lack of
mechanoprotection in these mutants. Our ﬁnding that Cav3 P28L
and R26Q myotubes still express caveolae at the plasma mem-
brane, albeit to a much lesser extent and with abnormal mor-
phology, most likely indicates that this number is too low to
assure an efﬁcient mechanoprotection and/or that these caveolae
are not fully functional as suggested by their aberrant size.
It is tempting to speculate that the increased fragility of the
mutant myotubes membrane could be related to the pathological
phenotype reported in Cav3-related muscle dystrophies. We were
however surprised that these defects were mainly observed when
mutant myotubes were subjected to a severe hypo-osmotic shock.
Mild hypo-osmotic shocks did not allow to reveal mechan-
oprotection defects in mutant myotubes. This is indeed in
agreement with early electron microscopy studies showing that
Aplysia californica smooth muscle and frog skeletal muscle ﬁbers
must be stretched up to nonphysiological levels such as three
times the in situ length in order to visualize the presence of
ﬂattened caveolae37,38. This is also consistent with the mild-to-
moderate clinical symptoms described in these patients39. We
further investigated this aspect with in vivo experiments in mice
(see Supplementary Methods). We transplanted WT GFP, P28L
GFP, or P28L Cav3-GFP transduced human myoblasts in severely
cryo-damaged tibialis anterior muscles (Supplementary Fig. 5).
For the three transplanted cell types, we observed mature muscle
ﬁbers containing identical numbers of human cells with nuclei
positive for human lamin A/C (Supplementary Fig. 5a, b) and
expressing human spectrin (Supplementary Fig. 5c). The locali-
zation of human nuclei in the ﬁbers was not affected either
(Supplementary Fig. 5d). These results indicate that the Cav3-
P28L mutated myoblasts maintain their potential to differentiate
in vivo after transplantation into regenerating muscles of mice.
Similar results were reported for several muscular dystrophies
including Duchenne and facioscapulohumeral muscular dystro-
phies that present more severe clinical disorders than the Cav3-
related muscle dystrophies studied here40. Importantly, our
in vivo experiments conﬁrmed the rescue results obtained in vitro
(Fig. 5b, c) since Cav3-GFP was located at the plasma membrane
after fusion of Cav3-GFP-rescued P28L myoblasts with mouse
ﬁbers (Supplementary Fig. 5a).
This incited us to explore other functions of caveolae that could
also be deregulated by caveolae dysfunction in Cav3 mutant
myotubes. We investigated the regulation of muscle cells signal-
ing as several signaling defects have been described in muscle
dystrophies and caveolae have long been associated with the
regulation of intracellular signaling. Indeed, Cav3 has been
involved in the regulation of distinct signaling pathways impor-
tant for muscle function such as calcium homeostasis41, the
insulin/GLUT4/Akt pathway42 or TrkA and EGFR signaling26.
We focused our analysis on the interleukin-6 (IL6)/
STAT3 signaling pathway which has been shown to play an
essential role in muscle tissue homeostasis43. In addition, the IL6
pathway is tightly associated to mechanical stress in muscle cells
as IL6 is secreted mostly during physical exercise44. IL-6 ligand
expression was also shown to be triggered by long-term osmotic
variations in non-muscle cells such as corneal epithelial cells and
Caco-2 cells45,46.
Our data show a major deregulation of the IL6/
STAT3 signaling pathway in the Cav3 mutant myotubes with a
constitutive hyperactivation of STAT3 at steady state. In com-
parison to WT myotubes, we found no signiﬁcant difference in
IL6Rα and gp130 total expression, the two subunits of the IL6
receptor, suggesting that the machinery of the IL6 signaling
pathway is not modiﬁed in those myotubes (Supplementary
Fig. 6a). Interestingly, a recent study reported that Cavin-1, a
constituent of caveolae, was required for the proper localization
of SOCS3 in endothelial cells at rest, and that STAT3 activation
was increased when Cavin-1 was depleted47. Although more
investigations are required, this regulation is unlikely to occur in
Cav3 P28L and Cav3 R26Q mutant myotubes as they express
similar levels of Cavin-1, and high levels of SOCS3 as expected
from Fig. 3g (Supplementary Fig. 6a).
The deregulation of the IL6/STAT3 signaling pathway trans-
lated into increased STAT3 nuclear translocation and expression
of MYH8, SOCS3, ACTC1, and ACTN2, genes that are known to
be regulated by STAT3 and that have been associated with muscle
development and regeneration. As for the defects in mechan-
oprotection, the deregulation of the IL6/STAT3 signaling path-
way could be reproduced by depleting healthy myotubes from
Cav3, indicating that the absence of Cav-3 and/or caveolae was
responsible for the hyperactivation of STAT3. More importantly,
we observed that IL6/STAT3 signaling was regulated by
mechanical stress in a Cav3-dependent manner in human
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myotubes. The regulation of IL6/STAT3 mechanosignaling by
caveolae was lost in Cav3-mutant myotubes or when healthy
myotubes were depleted of Cav3. Again, as observed for
mechanoprotection, the regulation of IL6 mechanosignaling
could be rescued in P28L Cav3 myotubes transduced by the WT
form of Cav3, supporting the role of bona ﬁde caveolae in the
regulation of these two processes.
The ﬁrst CAV3 mutation associated with muscle disorders was
described 20 years ago and today it has been extended to ﬁve
distinct genetic disorders: rippling muscle disease (RMD), distal
myopathies (DM), hyperCKemia (HCK), limb-girdle muscular
dystrophy 1C (LGMD-1C), and familial hypertrophic cardio-
myopathy (HCM)20,39. Although many studies have addressed
the role of these mutations in muscle damages, the underlying
mechanisms remain poorly characterized. Cav3 has been involved
in several aspects of muscle physiology including myoblast
fusion48 and T-tubules organization49. Moreover, Cav3 interacts
with the dystrophin complex50 and regulates the trafﬁcking of
dysferlin51, two important muscle proteins whose expression and
localization are deregulated in severe myopathies. It is therefore
likely that the mechanisms by which Cav3 mutations are
responsible for muscle dystrophies are multiple. Several
caveolin–protein interactions including signaling molecules such
as endothelial nitric oxide synthase (eNOS) or PTEN have been
proposed to occur through the caveolin scaffolding domain
(CSD)52, a 20 amino acid region within Cav1 and Cav3. We
found that cavtratin, a CSD mimicking peptide53 was able to
signiﬁcantly reduce the hyperactivation of the IL6/STAT3 path-
way in Cav3 P28L mutant myotubes (Supplementary Fig. 6c, d).
Together with the absence of the IL6R subunit and gp130 into
caveolae (Supplementary Fig. 6b), our data suggest that the reg-
ulation of IL6 mechanosignaling requires the interaction with
Cav3-CSD outside of caveolae. These results may imply that other
CSD-mediated signaling interactions could be mediated by
caveolae mechanics in muscle cells. In this context, it is inter-
esting that the Cav3 R26Q mutant myotubes demonstrated a
signiﬁcant increase in NO production22. Finally, proteomics
performed in CAV3 p.P104L transgenic mice, where Cav3 is also
retained at the Golgi apparatus, revealed signiﬁcant changes in
protein expression including signaling molecules54.
In conclusion, we describe a mechanism by which the Cav3
mutations can be deleterious in human myotubes. We uncovered
a new regulation of IL6/STAT3 signaling by caveolae under
mechanical stress. Our ﬁndings revealed a striking similarity
between the regulation of mechanoprotection and the control of
IL6/STAT3 signaling by caveolae under mechanical stress. Our
data conﬁrm that the retention of Cav3 P28L and R26Q in the
Golgi complex is responsible for the absence of functional and
morphologically deﬁned caveolae at the plasma membrane, which
in turn results in deﬁcient mechanoprotection and IL6/STAT3
mechanosignaling. The IL6/STAT3 pathway is tightly associated
with the regulation of muscle mass and size31,43. It is likely that
the alteration of mechanoprotection and muscle size, two critical
parameters for general muscle homeostasis, are deleterious for
muscle tissue integrity. It is therefore tempting to propose that the
caveolae-dependent mechano-regulation of the IL6/STAT3
pathway that we have unraveled here is critical to couple the
activation of the IL6/STAT3 pathway with the intensity of
mechanical stress that myotubes constantly experience during
their lifetime thereby preventing a chronic hyperactivation of IL6/
STAT3, through a negative feedback loop, that would be other-
wise pathological to muscle cells.
Methods
Cell lines. Human primary cells were obtained from EuroBioBank. P28L and R26Q
human myoblasts were immortalized by the platform for immortalization of
human cells of the Institute of Myology40. Brieﬂy, myoblasts were transduced with
lentiviral vectors encoding hTERT and cdk4 and containing puromycin (P28L) or
puromycin and neomycin (R26Q) selection markers. Transduced cells were
selected with puromycin (1 μg mL−1) for 6 days (P28L) or with puromycin (1 μg
mL−1) for 6 days and neomycin (1 mgmL−1) for 10 days (R26Q). Cells were
seeded at clonal density, and individual myogenic clones were isolated. For
caveolin-3 expression, immortalized WT and P28L myoblasts were transduced
with lentiviral vectors expressing WT caveolin-3 and a GFP reporter gene (MOI 5).
A GFP lentiviral vector was used as control (MOI 5).
Cell culture. All cells were grown at 37 °C under 5% of CO2. All myoblasts cell lines
were cultured in Skeletal Muscle Cell Growth Medium (Promocell) supplemented
with 20% FCS (Gibco, Life Technologies), 50 µgmL−1 of fetuine, 10 ngmL−1 of
epidermal growth factor, 1 ng mL−1 basic ﬁbroblast growth factor, 10 µg mL−1 of
insulin, and 0.4 µgmL−1 of dexamethasone (Promocell). Prior to any cell seeding,
surfaces (well, coverslip, patterned coverslips) are coated with 1% of matrigel (v/v)
(Sigma) for 15 min at 37 °C. For myoblast differentiation, conﬂuent cells (80–100%
conﬂuency) are put in DMEM high-glucose Glutamax (Gibco, Life Technologies),
supplemented with 0.1% of insulin (v/v) (Sigma) for 4 days.
Antibodies and reagents. Mouse anti-αTubulin (Sigma-Aldrich, clone B512,
T5168, 1/1000 for WB); mouse anti-caveolin-3 (Santa Cruz, clone A3, sc-5310, 1/
1000 for WB, 1/250 for IF); rabbit anti-caveolin-1 (Cell Signaling, 3238, 1/1000 for
WB, 1/500 for IF); goat anti-GM130 (Santa Cruz, clone P-20, sc-16268, 1/50 for
IF); mouse anti-MF20 (myosin heavy chain) (kind gift of Vincent Mouly, 1/100 for
WB, 1/20 for IF); mouse anti-STAT3 (Cell Signaling, clone 124H6, 9139, 1/1000 for
WB); rabbit anti-pSTAT3 (Cell Signaling, clone D3A7, 9145, 1/1000 for WB, 1/75
for IF); Secondary antibodies conjugated to Alexa FITC, Cy3, Cy5 (1/200 for IF) or
horseradish peroxidase (1/1000 for WB) (Beckman Coulter or Invitrogen). DAPI
(Sigma-Aldrich).
RNA interference-mediated silencing. Myoblasts were transfected with small
interfering RNAs (siRNAs) using HiPerFect (Qiagen) according to the manu-
facturer’s instructions at days 0 and 2 of differentiation and were cultured in
differentiation medium for a total of 4 days. Experiments were performed on the
validation of silencing efﬁciency by immunoblot analysis using speciﬁc antibodies
and normalizing to the total level of tubulin used as loading controls. 20 nM of a
pool of four siRNA targeting Cav3 were used (SI03068730, SI02625665,
SI02625658, and SI00146188, QIAGEN), Control siRNA (1022076, QIAGEN) was
used at the same concentration and served as a reference point (Supplementary
Table 1).
Immunoblotting. Cells were lysed in sample buffer (62.5 mM Tris/HCl, pH 6.0, 2%
v/v SDS, 10% glycerol v/v, 40 mM dithiothreitol, and 0.03% w/v phenol red).
Lysates were analyzed by SDS-PAGE and Western blot analysis and immuno-
blotted with the indicated primary antibodies and horseradish peroxidase-
conjugated secondary antibodies. Chemiluminescence signal was revealed using
Pierce™ ECL Western Blotting Substrate, SuperSignal West Dura Extended Dura-
tion Substrate or SuperSignal West Femto Substrate (Thermo Scientiﬁc Life
Technologies). Acquisition and quantiﬁcation were performed with the ChemiDoc
MP Imaging System (Bio-Rad) (Supplementary Fig. 7).
Immunoﬂuorescence. Myoblasts were grown and differentiated on coverslips for
4 days. For Cav3, Cav1, MF20, GM130 staining, cells are ﬁxed with 4% PFA (v/v)
(Sigma-Aldrich) for 10 min at RT, quenched in 50 mM NH4Cl and then per-
meabilized with 0.2% BSA (v/v) and 0.05% saponin (v/v) (Sigma-Aldrich) in PBS
for 20 min. Cells are incubated sequentially with indicated primary and
ﬂuorescence-conjugated secondary antibody in permeabilization buffer for 1 h at
RT. For pSTAT3 staining, cells are ﬁxed and permeabilized with cold methanol for
15 min at −20 °C. After washes with PBS 0.2% BSA (v/v), cells are incubated
sequentially with indicated primary and ﬂuorescence-conjugated secondary anti-
body in PBS 0.2% (v/v) for 1 h at RT. In both protocols, coverslips are mounted in
Fluoromount-G mounting medium (eBioscience) supplemented with 2 µg mL−1 of
DAPI (Sigma-Aldrich). Acquisitions of images are done using a spinning disk
microscope (inverted Spinning Disk Confocal Roper/Nikon; Camera: CCD 1392 ×
1040 CoolSnap HQ2; objective: ×60 CFI Plan Apo VC). Colocalization between
markers was quantiﬁed by the Manders’ coefﬁcient using ImageJ software colo-
calization plugin JACoP55.
Electron microscopy. Epon embedding was used to preserve the integrity of cell
structures. Myotubes were ﬁxed sequentially for 1 h at room temperature with
1.25% glutaraldehyde in 0.1 M Na-Cacodylate and then overnight at 4 °C.
Cells were washed extensively with 0.1 M Na-Cacodylate, pH 7.2. Membrane
ﬁxation was performed for 1 h at room temperature with 1% OsO4 in 0.1 M Na-
Cacodylate, pH 7.2. Cells were dehydrated by incubation with aqueous solutions of
ethanol at increasing concentrations (50, 70, 90, then 100%, each for 10 min at RT).
Embedding was ﬁnally performed in LX112 resin. Cells were inﬁltrated with a 1:1
LX112:ethanol solution, washed with LX112, and embedded overnight at 60 °C in
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LX112 resin. Ultrathin 65 nm sections were sliced using a Leica UCT
ultramicrotome and mounted on nickel formvar/carbon-coated grids for
observations. Contrast was obtained by incubation of the sections for 10 min in 4%
uranyl acetate followed by 1 min in lead citrate.
Electron micrographs were acquired on a Tecnai Spirit electron microscope
(FEI, Eindhoven, The Netherlands) equipped with a 4k CCD camera (EMSIS
GmbH, Münster, Germany)
Micropatterning. 18 mm coverslips were micropatterned as described previously56
using a photo-mask with lines of 10 µm of width, separated by 60 µm. In both force
measurements and membrane bursting assay, myoblasts are plated at conﬂuency
on line micropatterns coverslips coated with 1% of matrigel (v/v) (Sigma) for 15
min at 37 °C. Differentiation of myoblasts is achieved as described above in section
“Cell culture”.
Force measurements. Plasma membrane tethers were extracted from cells by a
concanavalin A (Sigma-Aldrich) coated bead (3 μm in diameter, Polysciences) trap-
ped in optical tweezers. The optical tweezers are made of a 1064 nm laser beam
(ytterbium ﬁber laser, λ= 1064 nm, TEM 00, 5W, IPG Photonics, Oxford, MA)
expanded and steered (optics by Elliot Scientiﬁc, Harpenden, UK) in the back focal
plane of the microscope objective (Apo-TIRF ×100 NA 1.45, Nikon). The whole setup
was mounted on a Nikon Eclipse-Ti inverted microscope. The sample was illuminated
by transmitted light, and movies were acquired at 10Hz with an EM-charge-coupled
device camera (Andor iXon 897) driven by Micro-Manager. The ﬁne movements and
particularly the translational movement necessary to pull the membrane tether were
performed using a custom-made stage mounted on a piezoelectric element (P753,
Physik Instrumente, Karlsruhe, Germany) driven by a servo controller (E665, Physik
Instrumente) and a function generator (Sony Tektronix AFG320).
Calibration was performed using an oscillatory modulation driven by a function
generator and measuring the response of the bead to an oscillatory motion of the
stage. We measured k= 159 pN µm−1. This relationship is linear in the laser power
range used for the experiments (0.4–1.2W).
The membrane tether was held at constant length to measure the static force.
For measuring membrane tension changes due to hypo-osmotic shock, a ﬁrst tether
was ﬁrst pulled at 300 mOsm (iso condition). A second tube was pulled on the
same cell 5 min after diluting the medium with MilliQ water to obtain 45 mOsm.
The position of the bead used to compute tether forces was detected from the
images using a custom ImageJ macro.
Membrane bursting assay. Line micropatterned myotubes are incubated in
5 µg mL−1 of calcein-AM (Life Technologies) and 50 µg mL−1 of DAPI (Sigma-
Aldrich) for 15 min at 37 °C in the dark. Medium was then switched back with
differentiation medium to wash out the excess of calcein-AM. The medium is then
switched again with a 30 mOsm hypo-osmotic shock medium obtained after a
dilution of 10% medium and 90% H2O, supplemented with 2 mgmL−1 of PI
(Sigma). Immediately after medium switching, pictures are taken every minute for
10 min using a video microscope (Inverted microscope Nikon Ti-E, Camera: CCD
1392 × 1040 CoolSnap HQ2, objective: ×10 CFI Fluor). The time of bursting cor-
responds to the mean of the bursting time (i.e., the ﬁrst frame where PI appears in
the nuclei) for each burst myotube in a given condition.
IL6 stimulation. Myotubes were starved 4 h by switching the differentiation
medium to DMEM medium. In resting conditions, cells are then stimulated by
switching the medium with DMEM with 0.2% BSA (w/v), supplemented with 10
ng mL−1 of human recombinant IL6 (R&D) for 0, 5, or 15 min at 37 °C. For hypo-
osmotic conditions, medium was ﬁrst switched to 75% hypo-osmotic shock (25%
DMEM, 75% H2O) for 5 min and then switched to the same medium supple-
mented with 10 ng mL−1 of IL6 for 5 more minutes at 37 °C. For stretching con-
ditions, myoblasts were differentiated on ﬁbronectin (Sigma-Aldrich) coated
stretchable plates (Uniﬂex® culture plate, Flexcell International) and were then
subjected or not to 30 min of cyclic stretch (10% elongation, 0.5 Hz), using the FX-
4000T TM Tension Plus device (Flexcell International), followed or not by 5 min of
10 ng mL−1 IL6 stimulation. Cells are lysed and samples are analyzed by immu-
noblotting. For the analysis, pSTAT3 levels were quantiﬁed by calculating the ratio
between pSTAT3 and STAT3, both normalized to Tubulin signal as follows:
(pSTAT/tubulinpSTAT)/(STAT/tubulinSTAT). For the analysis of pSTAT3 nuclear
translocation, myotubes were differentiated on coverslips, stimulated with IL6 as
described above for 0 or 15 min and were then ﬁxed for further immuno-
ﬂuorescence analysis. Quantiﬁcation corresponds to the ratio between the nuclei
and the cytoplasm of the mean pSTAT3 intensity.
Quantitative PCR. Cells were lysed and RNA extraction was performed using an
extraction kit (RNeasy Plus, Qiagen). Reverse-transcription reaction was performed
with 1 µg of RNA per reaction, using high capacity cDNA reverse-transcription kit
(Applied Biosystem). qPCR was performed on 50 ng of cDNA for a reaction in a
total volume of 20 µL, using TaqMan Gene Expression Assays (GAPDH:
Hs02786624_g1; ACTC1: Hs01109515_m1; MYH8: Hs00267293_m1; SOCS3:
Hs02330328_s1, ACTN2: Hs00153809_m1, Applied Biosystem) and a Lightcycler
480 Probes Master kit (Roche). Relative expression levels were calculated using
ΔΔCT method with fold changes calculated as 2−ΔΔCT.
Statistical analyses. All analyses were performed using GraphPad Prism version
6.0 and 7.0, GraphPad Software, La Jolla, CA, USA, www.graphpad.com. Two-
tailed (paired or unpaired) t-test was used if comparing only two conditions. For
comparing more than two conditions, Kruskal–Wallis test was used with Dunn’s
multiple comparison test (if comparing all conditions to the control condition).
Signiﬁcance of mean comparison is marked on the graphs by asterisks. Error bars
denote SEM or SD.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that the main data supporting the ﬁndings of this study are available
within the article and its Supplementary Information ﬁles. Extra data are available from
the corresponding authors upon request.
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